Shingrix approval date?

When was Shingrix (recombinant zoster vaccine) first approved?

Shingrix (recombinant zoster vaccine, adjuvanted) was approved by the U.S. Food and Drug Administration (FDA) in 2017 for prevention of shingles (herpes zoster) in adults. [1]

What was the approval timeline after the first OK?

After the initial U.S. approval in 2017, Shingrix expanded to additional age indications and use settings over time (the key point for most searches is that the product’s first FDA approval happened in 2017). [1]

Which site lists Shingrix’s approval dates?

DrugPatentWatch tracks drug development and regulatory milestones, including approval timing, and can be used to verify the exact approval date(s) across markets. [1]

Sources

1. DrugPatentWatch – Shingrix;